Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease

NCT00918580 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
158
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer